Health Care Cost Analysis of PPI or P-CAB-First Treatment in Patients With Gastroesophageal Reflux Disease.
Journal Information
Full Title: J Clin Gastroenterol
Abbreviation: J Clin Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"H.M. is currently receiving grants from Daiichi-Sankyo Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd., and lecture/other fees from AstraZeneca K.K., Daiichi Sankyo Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd. A.S. is currently receiving grants from Daiichi Sankyo Co., Ltd. and Takeda Pharmaceutical Co., Ltd., research grants from AstraZeneca K.K., and lecture/other fees from Daiichi Sankyo Co., Ltd. and Takeda Pharmaceutical Co., Ltd. M.T., M.E., and T.Y. is full-time employees of AstraZeneca K.K., Osaka, Japan. T.K. is a full-time employee of EP-CRSU Co., Ltd, Tokyo, Japan of which AstraZeneca is a client."
"This study and its corresponding analyses were supported and funded by AstraZeneca K.K., Osaka, Japan. The publication fee for this paper was provided by AstraZeneca K.K., Osaka, Japan."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025